229 related articles for article (PubMed ID: 24595456)
21. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
22. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.
Poindexter KM; Matthew S; Aronchik I; Firestone GL
Cell Biol Toxicol; 2016 Apr; 32(2):103-19. PubMed ID: 27055402
[TBL] [Abstract][Full Text] [Related]
23. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
Chartrain M; Riond J; Stennevin A; Vandenberghe I; Gomes B; Lamant L; Meyer N; Gairin JE; Guilbaud N; Annereau JP
PLoS One; 2012; 7(5):e36762. PubMed ID: 22675422
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo.
Chen Z; Forman LW; Williams RM; Faller DV
BMC Cancer; 2014 Feb; 14():90. PubMed ID: 24528676
[TBL] [Abstract][Full Text] [Related]
25. Honokiol inhibits melanoma stem cells by targeting notch signaling.
Kaushik G; Venugopal A; Ramamoorthy P; Standing D; Subramaniam D; Umar S; Jensen RA; Anant S; Mammen JM
Mol Carcinog; 2015 Dec; 54(12):1710-21. PubMed ID: 25491779
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
Kundu A; Quirit JG; Khouri MG; Firestone GL
Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
[TBL] [Abstract][Full Text] [Related]
27. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
[TBL] [Abstract][Full Text] [Related]
28. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
Biteghe FAN; Padayachee E; Davids LM; Chalomie NET; Ndong JC; Barth S
J Photochem Photobiol B; 2020 Oct; 211():111982. PubMed ID: 32866820
[TBL] [Abstract][Full Text] [Related]
29. Topoisomerase I inhibitors, shikonin and topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cells.
Zhang FL; Wang P; Liu YH; Liu LB; Liu XB; Li Z; Xue YX
PLoS One; 2013; 8(11):e81815. PubMed ID: 24303074
[TBL] [Abstract][Full Text] [Related]
30. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory regulation of stem-like cells in melanoma.
Lim MS; Wang JH; Power DG; Redmond HP
Melanoma Res; 2017 Feb; 27(1):1-7. PubMed ID: 27764061
[TBL] [Abstract][Full Text] [Related]
32. Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.
Calvani M; Bianchini F; Taddei ML; Becatti M; Giannoni E; Chiarugi P; Calorini L
Oncotarget; 2016 Aug; 7(32):51138-51149. PubMed ID: 27303923
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cells: lessons from melanoma.
La Porta C
Stem Cell Rev Rep; 2009 Mar; 5(1):61-5. PubMed ID: 19093230
[TBL] [Abstract][Full Text] [Related]
34. Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations.
Hartman ML; Talar B; Sztiller-Sikorska M; Nejc D; Czyz M
Oncotarget; 2016 Feb; 7(8):9026-40. PubMed ID: 26824319
[TBL] [Abstract][Full Text] [Related]
35. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S
BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136
[TBL] [Abstract][Full Text] [Related]
36. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
[TBL] [Abstract][Full Text] [Related]
37. Pien Tze Huang suppresses the stem-like side population in colorectal cancer cells.
Wei L; Chen P; Chen Y; Shen A; Chen H; Lin W; Hong Z; Sferra TJ; Peng J
Mol Med Rep; 2014 Jan; 9(1):261-6. PubMed ID: 24173665
[TBL] [Abstract][Full Text] [Related]
38. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
39. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
[TBL] [Abstract][Full Text] [Related]
40. Patent analysis as a tool for research planning: study on natural based therapeutics against cancer stem cells.
Arya R; Bhutkar S; Dhulap S; Hirwani RR
Recent Pat Anticancer Drug Discov; 2015; 10(1):72-86. PubMed ID: 25138131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]